Renaissance Technologies - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 150 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$4,015,000
-24.6%
744,813
+17.0%
0.01%
-20.0%
Q1 2016$5,328,000
+2413.2%
636,613
+3620.1%
0.01%
Q2 2015$212,000
-92.7%
17,113
-93.3%
0.00%
-100.0%
Q4 2014$2,886,000
+2.3%
255,413
-20.5%
0.01%
-12.5%
Q3 2014$2,820,000
-32.1%
321,213
-43.6%
0.01%
-20.0%
Q2 2014$4,151,000569,4130.01%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2015
NameSharesValueWeighting ↓
GARRISON BRADFORD & ASSOCIATES INC 98,001$661,0000.71%
Tekla Capital Management LLC 537,600$3,618,0000.49%
CAMBRIDGE TRUST CO 239,003$1,611,0000.17%
FARALLON CAPITAL MANAGEMENT LLC 1,067,538$7,185,0000.14%
Asset Management Group, Inc. 29,453$199,0000.14%
Magnetar Financial LLC 754,837$5,080,0000.11%
Trellus Management Company, LLC 11,000$74,0000.09%
JAMISON EATON & WOOD INC /NJ 42,042$283,0000.08%
WESTFIELD CAPITAL MANAGEMENT CO LP 1,491,850$10,055,0000.07%
NORTH AMERICAN MANAGEMENT CORP 45,000$303,0000.06%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders